These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 32039788)

  • 1. Causes of aberrant non-invasive prenatal testing for aneuploidy: A systematic review.
    Samura O; Okamoto A
    Taiwan J Obstet Gynecol; 2020 Jan; 59(1):16-20. PubMed ID: 32039788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting fetoplacental mosaicism during cfDNA-based NIPT.
    Neofytou M
    Curr Opin Obstet Gynecol; 2020 Apr; 32(2):152-158. PubMed ID: 31977337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninvasive prenatal screening in twin pregnancies with cell-free DNA using the IONA test: a prospective multicenter study.
    Khalil A; Archer R; Hutchinson V; Mousa HA; Johnstone ED; Cameron MJ; Cohen KE; Ioannou C; Kelly B; Reed K; Hulme R; Papageorghiou AT
    Am J Obstet Gynecol; 2021 Jul; 225(1):79.e1-79.e13. PubMed ID: 33460583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal aneuploidy screening by non-invasive prenatal testing of maternal plasma DNA sequencing with "false negative" result due to confined placental mosaicism: A case report.
    Li X; Ju D; Shi Y; Li Y; Dong H; Huang J; Zhang Y
    Medicine (Baltimore); 2020 Jul; 99(29):e20848. PubMed ID: 32702826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
    Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
    Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Confined placental origin of the circulating cell free fetal DNA revealed by a discordant non-invasive prenatal test result in a trisomy 18 pregnancy.
    Mao J; Wang T; Wang BJ; Liu YH; Li H; Zhang J; Cram D; Chen Y
    Clin Chim Acta; 2014 Jun; 433():190-3. PubMed ID: 24667696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of trisomy 7 mosaicism in noninvasive prenatal screening.
    Qi Y; Yang J; Hou Y; Guo F; Peng H; Wang D; Du Q; Yin A
    Hum Genomics; 2019 Apr; 13(1):18. PubMed ID: 30971315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it time to sound an alarm about false-positive cell-free DNA testing for fetal aneuploidy?
    Mennuti MT; Cherry AM; Morrissette JJ; Dugoff L
    Am J Obstet Gynecol; 2013 Nov; 209(5):415-9. PubMed ID: 23529082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
    Gray KJ; Wilkins-Haug LE
    Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing.
    Brison N; Neofytou M; Dehaspe L; Bayindir B; Van Den Bogaert K; Dardour L; Peeters H; Van Esch H; Van Buggenhout G; Vogels A; de Ravel T; Legius E; Devriendt K; Vermeesch JR
    Prenat Diagn; 2018 Mar; 38(4):258-266. PubMed ID: 29388226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placental, maternal, fetal, and technical origins of false-positive cell-free DNA screening results.
    Raymond Y; Fernando S; Menezes M; Mol BW; McLennan A; da Silva Costa F; Hardy T; Rolnik DL
    Am J Obstet Gynecol; 2024 Apr; 230(4):381-389. PubMed ID: 38008147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.
    Gil MM; Accurti V; Santacruz B; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):302-314. PubMed ID: 28397325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for trisomies by cfDNA testing of maternal blood in twin pregnancy: update of The Fetal Medicine Foundation results and meta-analysis.
    Gil MM; Galeva S; Jani J; Konstantinidou L; Akolekar R; Plana MN; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jun; 53(6):734-742. PubMed ID: 31165549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective clinical evaluation of Momguard non-invasive prenatal test in 1011 Korean high-risk pregnant women.
    Hu HJ; Lee MY; Cho DY; Oh M; Kwon YJ; Han YJ; Ryu HM; Kim YN; Won HS
    J Obstet Gynaecol; 2020 Nov; 40(8):1090-1095. PubMed ID: 31826681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordant circulating fetal DNA and subsequent cytogenetics reveal false negative, placental mosaic, and fetal mosaic cfDNA genotypes.
    Lebo RV; Novak RW; Wolfe K; Michelson M; Robinson H; Mancuso MS
    J Transl Med; 2015 Aug; 13():260. PubMed ID: 26260800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Application of Cell-Free DNA Sequencing-Based Noninvasive Prenatal Testing for Trisomies 21, 18, 13 and Sex Chromosome Aneuploidy in a Mixed-Risk Population in Iran.
    Garshasbi M; Wang Y; Hantoosh Zadeh S; Giti S; Piri S; Reza Hekmat M
    Fetal Diagn Ther; 2020; 47(3):220-227. PubMed ID: 31487708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.